Volume 1, Issue 1, March 2023

View Volume 1, Issue 1, March 2023

How to Apply the Canadian Obesity Clinical Practice Guidelines to People with Type 2 Diabetes
Consideration of Cannabinoids in the Treatment of Diabetic Peripheral Neuropathic Pain
Type 2 Diabetes Remission: An Overview
The Use of Biosimilar Insulins in 2023
Addressing NAFLD as a Type 2 Diabetes Complication Using the Emerging Paradigms in Diagnostic and Management Techniques

Published: 2023-03-21

Articles

How to Apply the Canadian Obesity Clinical Practice Guidelines to People with Type 2 Diabetes

Sue D. Pedersen, MD, FRCPC, DABOM

5–10
- PDF (en)
- PDF (fr)
Consideration of Cannabinoids in the Treatment of Diabetic Peripheral Neuropathic Pain

Taylor Lougheed, MD

11–15
- PDF (en)
- PDF (fr)
Type 2 Diabetes Remission: An Overview

Akshay Jain, MD, FRCPC, FACE, CCD, ECNU, DABOM

17–20
- PDF (en)
- PDF (fr)
The Use of Biosimilar Insulins in 2023

Sarah Monsonego, MD, FRCPC

21–25
- PDF (en)
- PDF (fr)
Addressing NAFLD as a Type 2 Diabetes Complication Using the Emerging Paradigms in Diagnostic and Management Techniques

Harpreet S. Bajaj, MD, MPH, FACE

27–30
- PDF (en)
- PDF (fr)